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Abstract
Background: Periodontitis and hypertension, both of which are chronic infl ammatory 
and asymptomatic in nature, have a high prevalence in the general population. 
Anticardiolipin (CL) antibodies are often directed against CL which is an important 
component of the inner mitochondrial membrane. Anti-CL antibodies can increase 
in chronic infection and infl ammation, thrombosis, stroke, myocardial infarction, and 
atherosclerosis. Hence, the study was aimed to elucidate a link between periodontitis 
and systemic infl ammatory status by estimating the serum anti-CL antibodies in patients 
with chronic periodontitis and essential hypertension.
Materials and Methods: A total of 60 patients who fulfi lled the inclusion and exclusion 
criteria were selected and divided into four equal groups: (1) Healthy controls, 
(2) Periodontally healthy-hypertensive, (3) Chronic periodontitis-hypertensive, 
and (4) Chronic periodontitis-systemically healthy. Serum samples collected from 
the patients were analyzed for anti-CL antibodies using a specifi c enzyme-linked 
immunosorbent assay kit. Statistical method; the data obtained were subjected to 
statistical analysis using t-test.
Results: Anti-CL antibody levels were elevated in chronic periodontitis-hypertensive 
patients (Group 3) (3.7600-0.29665) compared with other groups, followed by 
(Group 2) periodontally healthy-hypertensive (2.5200-0.22804) (P < 0.001).
Conclusion: Chronic periodontitis results in increased systemic infl ammatory burden 
that can further contribute to elevation of anti-CL antibodies in hypertensive patients.
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Periodontitis is an infl ammatory disease of the supporting 
tissues of the teeth caused by specifi c microorganisms or groups 
of specifi c microorganisms resulting in progressive destruction 
of the periodontal ligament and alveolar bone with pocket 
formation or recession or both.[1]
Hypertension is persistently raised blood pressure (BP) 
resulting from raised peripheral arteriolar resistance. In more 
than 90%, the cause of hypertension is unknown and it is termed 
essential hypertension which becomes more frequent as the age 
advances and appears to be related to genetics and obesity.[2]
It has been stated that the severity of periodontitis could be 
related to essential hypertension or vice versa but the molecular 
mechanism that links these diseases is not well characterized. 
Considering the infl ammatory characteristics of essential 
hypertension and periodontitis, it is possible that the two 
diseases aggravate each other.[2]
Cardiolipin (CL) constitutes about 20% of the total lipid 
composition found in the inner mitochondrial membrane of all 
cells where it is essential for the optimal function of numerous 
enzymes that are involved in mitochondrial energy metabolism. 
Anti-CL antibodies are those often directed against CL, and 
elevated levels are often found in infections, systemic lupus 
erythematosus, anti-phospholipid syndrome, and Behcet’s 
disease.[3]
It is hypothesized that the anti-CL antibodies may promote 
various pathogenic mechanisms through endothelial activation 
by upregulating adhesion molecule expression, monocytes, and 
platelet adherence and by accelerating atherosclerosis.[4]
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The relationship between bacterial infections and anti-CL 
antibodies has been reported.[3] Systemic infl ammation caused by 
chronic periodontitis might aﬀ ect the serum anti-CL antibodies 
in individuals with essential hypertension, and elevated levels 
of this antibody might have a role in the association between 
chronic periodontitis and essential hypertension.[2]
Therefore, the aim of this study was to investigate the 
infl uence of chronic periodontitis on the levels of anti-CL 
antibodies in individuals with essential hypertension.
Materials and Methods
This was a cross-sectional study in patients visiting the Clinical 
Department of Periodontics between December 2008 and 
November 2009. The protocol was approved by the Institutional 
Human Ethical Committee of Rajah Muthiah Institute of Health 
Sciences.
Patient selection
The study population included 60 patients (32 males and 
28 females) in the age 35-50 who were willing to participate 
in the study, and an informed consent was obtained from all 
participants. Patients were divided into four groups with 15 in 
each group as follows:
• Group 1: Periodontally and systemically healthy (6 males 
and 9 females)
• Group 2: Periodontally healthy-hypertensive (10 males and 
5 females)
• Group 3: Chronic periodontitis-hypertensive (8 males and 
7 females)
• Group 4: Chronic periodontitis-systemically healthy 
(8 males and 7 females).
Criteria for hypertension and chronic periodontitis
Hypertension
Those with systolic BP >140 mm Hg and/or a diastolic BP >90 
mm Hg (as per the USA Joint National Committee guidelines) 
who were under antihypertensive medications for at least 
2 years.[2]
Chronic periodontitis
Those with clinical signs of periodontitis including probing 
pocket depth (PPD) of ≥5 mm with bleeding on probing (BoP) 
and clinical attachment loss (CAL) of ≥3 mm at 30% of sites or 
more with radiographic evidence of bone loss.[2]
Exclusion criteria
1. Smokers
2. Individuals with secondary hypertension or other systemic 
diseases
3. Pregnant and lactating women
4. Those taking lipid lowering or immunosuppressive drugs
5. History of periodontal treatment in preceding 6 months and 
taking antibiotics or anti-infl ammatory drugs within past 
3 months of our study period.
Study design
In the initial visit, all patients who fulfi lled the inclusion and 
exclusion criteria were examined clinically with a detailed medical 
history. According to the fi ndings, they were assigned to one of 
the four groups mentioned. The clinical periodontal parameters, 
including PPD,[5] BoP,[6] and CAL[5] were determined at six sites 
per tooth and recorded in a pro forma. A series of full-mouth 
intraoral periapical radiographs was taken for those patients 
with periodontitis to ascertain bone loss and confi rm the clinical 
diagnosis. All clinical examinations were performed by a single 
calibrated examiner (BP).
Sample collection
About 5 ml of blood sample was taken from each patient by 
venipuncture from an antecubital vein using Vacutainer tube.
Principle of enzyme-linked immunosorbent assay (ELISA)
All blood samples were analyzed in the same laboratory. An 
ELISA and standard serum were used to measure the IgG anti-
CL levels using AESKULISA™ anti-CL IgG ELISA kit, and the 
levels of antibodies were expressed in G phospholipids units.
Serum samples diluted 1:101 were incubated in the 
microplates coated with the specifi c antigen. Patient’s 
antibodies, if present in the specimen, would bind to the antigen. 
The unbound fraction was washed oﬀ , and then, antihuman 
immunoglobulins (conjugated) was incubated. This would react 
with the antigen-antibody complex of the samples in the micro 
plates if antibodies were present in the specimen. Unbound 
conjugate was washed oﬀ . Addition of tetramethylbenzidine 
substrate would generate an enzymatic calorimetric (blue) 
reaction, which would be stopped by diluted acid (color changes 
to yellow). The rate of color formation acts as a function of 
the amount of conjugate bound to antigen-antibody complex, 
and this was proportional to the initial concentration of the 
antibodies in patient’s sample.
Statistical analysis
The data obtained from clinical and biochemical evaluations 
were subjected to statistical analysis, and t-test was applied to 
compare the values between the groups.
Results
When IgG anti-CL antibody values were compared between 
healthy controls (Group 1) (1.5200 ± 0.16432) and 
periodontally healthy-hypertensive group (Group 2) (2.5200 ± 
0.22804), the anti-CL antibody levels were signifi cantly higher 
in Group 2 [Table 1] (P < 0.001).
Table 2 shows a comparison of IgG anti-CL antibody levels 
between periodontally healthy-hypertensive (Group 2) and chronic 
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periodontitis-hypertensive (Group 3). The anti-CL antibody 
levels were signifi cantly higher in Group 3 (3.7600 ± 0.29665) 
than Group 2 (2.5200 ± 0.22804) (P < 0.001).
Table 3 shows a comparison of IgG anti-CL antibody levels 
between healthy controls (Group 1) and chronic periodontitis-
systemically healthy (Group 4). There was no signifi cant 
diﬀ erence between the Group 1 (1.5200 ± 0.16432) and 
Group 4 (1.4600 ± 0.11402) (P = 0.305).
Table 4 shows a comparison of IgG anti-CL antibody levels 
between chronic periodontitis-hypertensive (Group 3) and 
chronic periodontitis-systemically healthy (Group 4). The 
anti-CL antibody levels were signifi cantly higher in Group 3 
(3.7600 ± 0.29665) than Group 4 (1.4600 ± 0.11402) 
(P < 0.001).
Discussion
The present study was conducted to determine the anti-CL 
antibodies in serum of patients with hypertension, chronic 
periodontitis with and without hypertension, and compare the 
same with the healthy controls.
The study included 60 patients (32 males and 28 females) in 
the age 35-50 who were willing to participate in the study, and 
an informed consent was obtained from all participants. Patients 
were divided into four groups with 15 in each group as follows:
• Group 1: Periodontally and systemically healthy (6 males 
and 9 females)
• Group 2: Periodontally healthy-hypertensive (10 males and 
5 females)
• Group 3: Chronic periodontitis-hypertensive (8 males and 
7 females)
• Group 4: Chronic periodontitis-systemically healthy 
(8 males and 7 females).
Results of our study have shown that the serum anti-CL 
antibody levels were signifi cantly higher in patients with 
chronic periodontitis and hypertension than those with only 
hypertension. These fi ndings were similar to that of Türkoglu 
et al.,[2] who in their study observed elevated levels of serum anti-
CL antibodies and oxidized low-density lipoprotein levels in 
chronic periodontitis patients with essential hypertension.
The elevation of anti-CL antibodies in sera of patients with 
chronic periodontitis and hypertension could be attributed to 
the reason for both periodontitis and hypertension are chronic 
in nature with acute episodic manifestations. Patients with 
periodontitis have not only local periodontal infl ammation 
but also had higher infl ammation in their blood stream. They 
also had higher concentrations of circulating granulocytes, 
CRP, fi brinogen, serum amyloid, and a host of other cytokines. 
Evidence is consistent with the notion that generalized severe 
periodontitis causes systemic infl ammation and endothelial 
dysfunction.[7]
Furthermore, it was evident from the results of our study 
that the anti-CL antibody levels were signifi cantly higher in 
periodontitis patients with and without hypertension as well 
as in patients with only hypertension when compared with 
periodontally and systemically healthy individuals. This was in 
accordance with the study done by Schenkein et al.,[3] who found 
elevated anti-CL antibodies in periodontitis group compared to 
healthy control.
Periodontal infection is associated with Gram-negative 
bacteremia, and this, in turn, leads to endothelial damage, platelet 
aggregation, and monocytic infi ltration and proliferation. These 
monocytes produce various infl ammatory cytokines such as 
interleukin-1, tumor necrosis factor-alpha, and interleukin-6, 
which can damage the endothelium. Damaged endothelium 
activates platelets which, in turn, results in platelet aggregation, 
and this, in turn, also potentiate thromboembolic events.[8] 
Similarly, Harvey et al.[9] studied anti-CL antibodies and serum 
adhesion molecule levels in patients with aggressive periodontitis 
and revealed that a subset of periodontitis patients with elevated 
anti-phospholipid antibodies could represent a subgroup with 
increased risk for obstetrical and cardiovascular sequel.
Chronic periodontitis might be associated with an increased 
level of anti-CL antibodies. This could be due to periodontal 
Table 1: Comparison of anti-CL antibody levels (GPL units) 
between Groups 1 and 2
Groups n Mean Standard 
deviation




t-value 22.361, P<0.001 (S). CL: Cardiolipin, GPL: G phospholipids
Table 2: Comparison of anti-CL antibody levels (GPL units) 
between Groups 2 and 3
Groups n Mean Standard 
deviation
2.  Periodontally healthy-hypertensive 15 2.5200 0.22804
3.  Chronic periodontitis-hypertensive 15 3.7600 0.29665
t-value 13.371, P<0.001 (S). CL: Cardiolipin, GPL: G phospholipids
Table 3: Comparison of anti-CL antibody levels (GPL units) 
between Groups 1 and 4
Groups n Mean Standard 
deviation
1. Healthy control 15 1.5200 0.16432
4.  Chronic periodontitis-systemically 
healthy
15 1.4600 0.11402
t-value 1.177, P=0.305 (NS). CL: Cardiolipin, GPL: G phospholipids
Table 4: Comparison of anti-CL antibody levels (GPL units) 
between Groups 3 and 4
Groups n Mean Standard 
deviation
3.  Chronic Periodontitis-hypertensive 15 3.7600 0.29665
4.  Chronic Periodontitis-systemically 
healthy
15 1.4600 0.11402
t-value 20.172, P<0.001 (S). CL: Cardiolipin, GPL: G phospholipids
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pathogens, especially Gram-negative bacteria, which induce the 
production of systemic infl ammatory markers.[10]
Our results are consistent with those of Goteiner et al.,[11] 
who found increased levels of serum anti-CL antibodies in 
chronic periodontitis patients suﬀ ering from essential BP. They 
suggested that increasing anti-CL antibody levels could increase 
the risk of atherosclerosis in these patients.
The few limitations of our study were not taking genetic 
factors into consideration and not evaluated other systemic 
markers such as CRP levels as well as not doing a microbiological 
profi le.
Conclusion
Within the few limitations of our study, it can be concluded 
that the results of our study clearly determined elevated anti-
CL antibody levels in patients with chronic periodontitis 
and hypertension together followed by those with either 
hypertension or chronic periodontitis than the healthy controls. 
Thus, chronic periodontitis, when occurs in tandem with 
essential hypertension may considerably increase the risk of 
atherosclerosis due to increased anti-CL antibody levels. This 
gives rise to serious health concerns in patients with essential 
hypertension and chronic periodontitis.
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